Frankie Fattorini

2 weeks ago | pharmaceutical-technology.com | Frankie Fattorini

The slowdown in IPOs following tariff-associated turbulence and FDA reorganisation will soon pass, say industry investors. Panellists Dirk Kersten, Max Klement, Alastair Kilgour, and John Rudy at LSX World Congress 2025 projected an eventual return of biotech IPOs following the current drought. Credit: Frankie Fattorini / GlobalData.

2 weeks ago | pharmaceutical-technology.com | Frankie Fattorini

Funding troubles and innovation responsibilities are falling more heavily on emerging biotechs under strain from US developments. Hard times are ahead for biotechs as the funding drought is set to worsen, with increased investor uncertainty following Trump tariffs and FDA cuts, said Cody Powers, partner at ZS Associates, speaking at the LSX World Congress 2025. Credit: Frankie Fattorini / GlobalData.

1 month ago | pharmaceutical-technology.com | Frankie Fattorini

Skip to site menuSkip to page content US President Donald Trump has issued a broad executive order to lower prescription drug prices in the country, notably including a directive to ease price negotiation for small molecule drugs.

1 month ago | clinicaltrialsarena.com | Frankie Fattorini

AI is said to be exponentially faster and effective at writing lengthy and complex clinical trial documents, but those using the technology see some limitations, which could mean a role for human medical writers endures. Large language models (LLMs) can draft clinical documents in a fraction of the time their human counterparts need. Growing interest from the pharmaceutical industry to harness this technology has therefore made specialised writers worry their livelihood is under threat.

1 month ago | pharmaceutical-technology.com | Frankie Fattorini

Skip to site menuSkip to page content AI is said to be exponentially faster and effective at writing lengthy and complex clinical trial documents, but those using the technology see some limitations, which could mean a role for human medical writers endures. Large language models (LLMs) can draft clinical documents in a fraction of the time their human counterparts need.